If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
28.00    1.00 (3.70%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £13.34m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Year-End Trading Update

7 Feb 2024 07:00

RNS Number : 2538C
Pennant International Group PLC
07 February 2024
 

FOR IMMEDIATE RELEASE 7 February 2024

 

PENNANT INTERNATIONAL GROUP PLC

 

Trading Update

 

Record Gross Margin & Return to Operating Profit

?

Appointment of Non-Executive Director (Chair Designate)

 

Pennant International Group plc (AIM:PEN)(the "Company", the "Group"), the IPS software and services company, is pleased to provide the following trading update ahead of the publication of the Company's full-year results for the year ended 31 December 2023 ("FY23"), which are scheduled to be announced in April 2024.

 

The preliminary unaudited assessment of the Group's trading for FY23 indicates:

 

· Group revenues of £15.5 million (2022: £13.7 million);

· gross margin of 50%, a record for the Group (2022: 42%);

· adjusted earnings before interest and tax (EBIT) of £0.4 million (2022: EBIT loss of £1.0 million)

· adjusted earnings before interest, taxation and amortisation (EBITA) of £1.7 million (2022: EBITA of £0.5 million);

· adjusted earnings before interest, taxation, depreciation and amortisation (EBITDA) of £2.2 million (2022: EBITDA of £1.1 million);

· net debt at year-end of £1.9 million (2022: net debt of £0.4 million), with post year-end receipts resulting in net cash of £0.3 million during week commencing 15 January.

 

Note: the above results are adjusted for circa £0.3 million of exceptional, non-recurring costs, including transaction and integration costs associated with the acquisition of Track Access Productions Limited in April 2022, and professional costs and expenses associated with another, aborted transaction.

 

Appointment of Non-Executive Director (Chair Designate)

 

The Company is pleased to announce that Ian Dighé has been appointed to the Board as an independent non-executive director and Chair designate. Phil Cotton will step down as Chair at the Company's next Annual General Meeting which is expected to be held in May 2024, to be succeeded by Ian. Following the AGM, Phil Cotton will continue to serve on the Board as an independent non-executive director.

 

Ian has significant listed company and City experience, particularly in the investment banking, corporate broking, asset management and closed-end funds sectors. He is also experienced at developing boards and their senior management teams, and looks forward to leading the Board as the Group continues to implement its strategy.

 

 

Chief Executive Officer, Philip Walker commented: "The Board is very pleased with the Group's positive, and improving, trading performance. The results, which include a return to operating profit and a record gross margin of 50 per cent, are strong indicators that Pennant's growth strategy is delivering. However, there is much still to do as we head into the next phase, and we are therefore delighted to welcome Ian, whose appointment will further strengthen the Board as we move forward. I would also like to take this opportunity to thank Phil Cotton on behalf of the Board for his valuable contribution as Chair."

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended ("MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.com

Philip Walker, CEO

David Clements, Commercial & Risk Director

Michael Brinson, CFO

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

 www.whirelandplc.com/capital-markets

Mike Coe / Sarah Mather (Corporate Finance)

+44 (0) 20 7220 1666

Fraser Marshall / George Krokos (Sales)

 

 

 

 

Walbrook PR (Financial PR)

pennant@walbrookpr.com

Paul Vann

Joe Walker

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUNUORSWUURUR
Date   Source Headline
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change
1st Nov 20211:23 pmRNSHolding in Company
28th Oct 20212:26 pmRNSHolding in Company
12th Oct 20212:44 pmRNSGrant of Option
30th Sep 20215:02 pmRNSHolding in Company
28th Sep 20214:31 pmRNSHolding in Company
27th Sep 20215:02 pmRNSHolding(s) in Company
23rd Sep 20217:00 amRNSDirector/PDMR Share Purchases
22nd Sep 20217:00 amRNS2021 Interim Results
7th Sep 20212:44 pmRNSHolding in Company
31st Aug 20212:05 pmRNSSecond Price Monitoring Extn
31st Aug 20212:00 pmRNSPrice Monitoring Extension
31st Aug 20217:00 amRNSTrading Update & Notice of Interim Results
2nd Jun 20214:48 pmRNSResults of AGM & Appointment of new Chairman
27th May 20217:00 amRNSAGM Update
29th Apr 20213:31 pmRNSNotice of AGM
28th Apr 20212:05 pmRNSSecond Price Monitoring Extn
28th Apr 20212:00 pmRNSPrice Monitoring Extension
28th Apr 20217:00 amRNS2020 Final Results
19th Apr 20217:00 amRNSRescheduling of 2020 Final Results
1st Apr 20214:46 pmRNSIssue of Equity & Director Dealings
10th Mar 20217:00 amRNSNotice of Final Results
9th Mar 20217:00 amRNSHoldings in Company
9th Mar 20217:00 amRNSHoldings in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
6th Oct 20202:00 pmRNSHolding(s) in Company
5th Oct 202011:02 amRNSHolding(s) in Company
5th Oct 202011:01 amRNSHolding(s) in Company
5th Oct 202011:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.